JANX
Janux Therapeutics Inc
16.30$
-2.3%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| – | – | +857.1% | +136.8% | -6.1% | +31.0% | -5.6% | |
| – | +116.7% | +281,176.9% | +107.0% | -97.4% | +5.4% | -1.5% | |
| – | – | – | +136.8% | -28.8% | +39.2% | -6.5% | |
| – | +1.4% | +762.8% | +103.7% | +2.8% | +24.5% | +84.1% | |
| – | +133.4% | +473.2% | +115.5% | +17.4% | +57.0% | +1.8% | |
| – | +28.1% | +657.1% | +107.0% | +4.5% | +35.7% | +54.3% | |
| – | – | – | – | – | – | – | |
| – | -11.6% | +79.6% | +989.7% | – | – | – | |
| – | – | – | – | – | – | – | |
| – | -756.2% | – | – | – | – | – | |
| – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.